QF
ARRY

QVT Financial’s Array Biopharma Inc ARRY Stock Holding History

QVT Financial’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-361,722
Closed -$1.71M – 103
2014
Q4 		$1.71M Sell
361,722
-2,029,478
-85% -$8.03M 0.09% 87
2014
Q3 		$8.54M Buy
2,391,200
+295,000
+14% +$1.16M 0.44% 54
2014
Q2 		$9.56M Sell
2,096,200
-160,000
-7% -$662K 0.52% 57
2014
Q1 		$10.6M Sell
2,256,200
-377,400
-14% -$1.9M 0.61% 51
2013
Q4 		$13.2M Sell
2,633,600
-245,000
-9% -$1.33M 0.77% 44
2013
Q3 		$17.9M Sell
2,878,600
-558,693
-16% -$3.32M 1.22% 30
2013
Q2 		$15.6M Buy
+3,437,293
New +$18.5M 1.05% 36

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return